MedPath

Studies on the antihypertensive effect and uric acid metabolism by the combination therapy of ARB and diuretics in the CKD patients with hypertension - Comparison between daily and alternate-daily medication of diuretics

Not Applicable
Recruiting
Conditions
The CKD patients with hypertension
Registration Number
JPRN-UMIN000010170
Lead Sponsor
Department of Internal Medcine, Teikyo University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) The patient with contraindication of irbesartan medication 1. Patients with a history of hypersensitivity to any component of this drug 2. Patients during pregnancy and with pregnant possibility 2) The patient with contraindication of the trichrolmethiazide medication 1. Patients with anuria 2. Patients with acute renal failure 3. Patients with hyponatremia, and hypokalemia 4. Patients with a history of hypersensitivity to thiazides or analogues 3) Patients who are judged ineligible for any other reasons by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Change of blood pressure (office blood pressure, home blood pressure) 2. Changes of serum uric acid level
Secondary Outcome Measures
NameTimeMethod
1. Changes in renal function (serum creatinine, eGFR, serum cystatin C et al.) 2. Changes in urinary examinations (urine protein et al.) 3. Changes of metabolic biomarkers (lipids, glucose and electrolytes) 4. Changes of heart rate
© Copyright 2025. All Rights Reserved by MedPath